Inclusive of all taxes
GABASIGN 800 CAP by Dr Precision is a high-potency pharmaceutical capsule containing 800 mg of Gabapentin, formulated specifically for the effective management of chronic neuropathic pain and as an adjunct treatment for partial-onset seizures. Manufactured under strict WHO-GMP standards by BluepillExpress, an industry-leading Indian third-party manufacturer, this product ensures global compliance and quality excellence suitable for regulated and semi-regulated markets worldwide. The capsule's advanced formulation enables precise modulation of voltage-gated calcium channels in neurons, reducing nerve excitability and abnormal firing to alleviate conditions such as diabetic peripheral neuropathy, postherpetic neuralgia, fibromyalgia, and central pain syndromes. Ideal for chronic and severe neurological conditions, GABASIGN 800 CAP supports less frequent dosing due to sustained drug levels, making it a preferred choice for long-term therapy. It stands out for its safety profile as a non-addictive, non-sedative alternative to opioids, with consistent efficacy backed by rigorous manufacturing and quality control processes. Available for bulk purchase, custom branding, and private labeling, GABASIGN 800 CAP fits the needs of distributors, healthcare professionals, and pharmaceutical companies seeking trusted neurology-focused treatments in B2B markets.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Gabapentin 800 mg per capsule |
| Therapeutic Use | Adjunct treatment of partial seizures and neuropathic pain management |
| Manufacturing Standards | Produced under WHO-GMP certified facilities by BluepillExpress |
| Global Compliance | Meets regulatory requirements for export to regulated and semi-regulated markets |
| Mechanism of Action | Modulates α2δ subunit of voltage-gated calcium channels reducing excitatory neurotransmitter release |
| Dosage Form | Capsule for oral administration |
| Dosing Frequency | Typically administered 2-3 times daily; suitable for high-dose stable long-term treatment |
| Pharmacokinetics | Dose-dependent absorption, Tmax 2-3 hours, half-life 5-7 hours, primarily renal elimination |
| Safety Profile | Non-sedative, non-addictive alternative to opioids |
| Customization Options | Available for bulk supply, private labeling, and custom branding |
| Attributes | Description |
|---|---|
| Capsule Content | 800 mg Gabapentin |
| Indications | Diabetic peripheral neuropathy, Postherpetic neuralgia, Partial seizures adjunct therapy, Fibromyalgia (off-label), Central pain syndrome, Nerve pain from spinal cord injuries or shingles |
| Pharmacodynamics | Binds α2δ subunit on voltage-gated calcium channels inhibiting excitatory neurotransmitters |
| Bioavailability | Decreases with increasing dose (dose-dependent absorption) |
| Time to Peak Concentration (Tmax) | 2 to 3 hours post-dose |
| Elimination Half-life | 5 to 7 hours |
| Metabolism | Negligible hepatic metabolism |
| Excretion | Primarily renal, unchanged |
| Packaging Options | Bulk supply and customizable packaging available |
| Manufacturing Location | India (BluepillExpress) |
| Regulatory Compliance | WHO-GMP certified |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
GABASIGN 800 CAP is manufactured under strict WHO-GMP guidelines by BluepillExpress, ensuring compliance with international quality and regulatory standards, making it appropriate for export to regulated and semi-regulated markets worldwide.
Yes, while primarily indicated for neuropathic pain and partial seizures, GABASIGN 800 CAP is also used off-label for fibromyalgia, providing relief from chronic nerve-related pain conditions.
The 800 mg high-dose capsule allows for enhanced control of neuropathic symptoms with less frequent dosing, which improves patient compliance in chronic and severe cases requiring sustained therapeutic levels.
Yes, GABASIGN 800 CAP provides a non-sedative and non-addictive alternative to opioid treatments, making it safer for long-term management of neuropathic pain and seizure adjunct therapy.
Yes, BluepillExpress offers GABASIGN 800 CAP for bulk supply with options for private labeling and custom branding, catering to the specific requirements of distributors and pharmaceutical businesses.
Country Of Origin: India
GABASIGN 800 CAP contains Gabapentin 800 mg, a powerful antiepileptic and neuropathic pain-relieving agent. Manufactured under strict WHO-GMP guidelines by BluepillExpress, this high-strength formulation is designed for effective control of severe nerve pain and adjunct treatment in seizure disorders. Ideal for chronic cases requiring strong, sustained relief, it is trusted by global markets for safety, efficacy, and regulatory compliance.
This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.
GABASIGN 800 CAP is a high-potency formulation containing Gabapentin 800 mg, developed to provide effective relief from chronic neuropathic pain and as an adjunctive therapy in the treatment of partial-onset seizures. Gabapentin is a structural analogue of GABA (gamma-aminobutyric acid) that modulates calcium channels in the nervous system to reduce nerve excitability and pain signaling.
This advanced pharmaceutical product is manufactured by BluepillExpress, a leading Indian third-party manufacturing company globally recognized for quality, regulatory excellence, and consistent supply chain execution. Each capsule is manufactured using advanced machinery and under rigorous quality control to meet global export requirements across regulated and semi-regulated markets.
Indications
Diabetic peripheral neuropathy
Postherpetic neuralgia
Partial seizures (adjunct therapy)
Fibromyalgia (off-label use)
Central pain syndrome
Nerve pain from spinal cord injuries or shingles
Mechanism of Action
Gabapentin acts by binding to the α2δ subunit of voltage-gated calcium channels in neurons, inhibiting the release of excitatory neurotransmitters such as glutamate, substance P, and norepinephrine. This helps reduce abnormal nerve firing and relieves neuropathic pain and seizures.
Dosage & Administration
Typical Dose Range: 300–3600 mg/day
GABASIGN 800 CAP is used in patients titrated to higher daily doses for stable long-term management
Dose to be taken as prescribed by a physician; often administered 2-3 times per day
Must not be stopped abruptly; gradual tapering is advised
Pharmacokinetics
Absorption: Dose-dependent (bioavailability decreases with increasing dose)
Tmax: 2–3 hours post-administration
Half-life: 5–7 hours
Elimination: Renal (unchanged)
Metabolism: Not significantly metabolized in the liver
Advantages of GABASIGN 800 CAP
High-dose capsule provides enhanced control of neuropathic symptoms
Non-sedative and non-addictive alternative to opioids
Suitable for patients who require less frequent dosing due to sustained concentration
Manufactured under GMP-certified facilities with complete quality assurance
Available for custom branding, bulk supply, and private labeling
Inclusive of all taxes
You Save: 0
Surat , India
Manufacturer, Contractor, Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler, Startup
GST- 24abdfb4194j1ze
